miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas.

MLA

Li, Shouwei, et al. “MiR-423-5p Contributes to a Malignant Phenotype and Temozolomide Chemoresistance in Glioblastomas.” Neuro-Oncology, vol. 19, no. 1, Jan. 2017, pp. 55–65. EBSCOhost, https://doi.org/10.1093/neuonc/now129.

APA

Li, S., Zeng, A., Hu, Q., Yan, W., Liu, Y., & You, Y. (2017). miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas. Neuro-Oncology, 19(1), 55–65. https://doi.org/10.1093/neuonc/now129

Chicago

Li, Shouwei, Ailiang Zeng, Qi Hu, Wei Yan, Yanwei Liu, and Yongping You. 2017. “MiR-423-5p Contributes to a Malignant Phenotype and Temozolomide Chemoresistance in Glioblastomas.” Neuro-Oncology 19 (1): 55–65. doi:10.1093/neuonc/now129.